Unknown

Dataset Information

0

Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

ABSTRACT:

SUBMITTER: Thaker V 

PROVIDER: S-EPMC6517261 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
| S-EPMC4465600 | biostudies-literature
Unknown Cystic fibrosis transmembrane conductance regulator function, not TAS2R38 gene haplotypes, predict sinus surgery in children and young adults with cystic fibrosis.
| S-EPMC7266728 | biostudies-literature
Unknown Yoga as a Therapy for Adolescents and Young Adults With Cystic Fibrosis: A Pilot Study.
| S-EPMC4653591 | biostudies-literature
Unknown Perspectives on long-acting growth hormone therapy in children and adults.
| S-EPMC7237337 | biostudies-literature
Unknown Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis.
| S-EPMC9319690 | biostudies-literature
Unknown COVID-19: Impact, experiences, and support needs of children and young adults with cystic fibrosis and parents.
| S-EPMC8441823 | biostudies-literature
Unknown Health-Related Quality of Life of Young Adults Treated with Recombinant Human Growth Hormone during Childhood.
| S-EPMC4608786 | biostudies-literature
Unknown Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes.
| S-EPMC5722914 | biostudies-literature
Other Environmental exposures and inflammation in young children with cystic fibrosis
2018-10-10 | ST001079 | MetabolomicsWorkbench
Unknown Abnormal Glucose Tolerance in Infants and Young Children with Cystic Fibrosis.
| S-EPMC5067820 | biostudies-literature